An ever-increasing metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: what are problems and countermeasures?

Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):941-944. doi: 10.21037/hbsn-23-538. Epub 2023 Nov 9.
No abstract available

Keywords: Hepatoma; hepatic steatosis; lenvatinib (LEN); metabolic syndrome; viral hepatitis.

Publication types

  • Editorial
  • Comment